Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.74%480.801.0%$554.19m
ABTAbbott Laboratories -1.43%107.030.8%$504.83m
DHRDanaher Corp. -2.55%233.660.7%$504.16m
MDTMedtronic Plc -2.09%103.010.6%$426.75m
ALGNAlign Technology, Inc. -2.85%442.126.4%$393.88m
ISRGIntuitive Surgical, Inc. -3.64%694.692.3%$364.58m
BSXBoston Scientific Corp. -5.28%34.151.0%$310.10m
DXCMDexCom, Inc. -7.56%351.867.9%$306.74m
BDXBecton, Dickinson & Co. -2.79%237.421.0%$259.23m
QDELQuidel Corp. -3.18%264.897.7%$237.82m
BAXBaxter International, Inc. -2.56%78.561.8%$196.07m
SYKStryker Corp. -3.91%205.121.3%$191.07m
VARVarian Medical Systems, Inc. -0.24%172.559.1%$187.42m
EWEdwards Lifesciences Corp. -3.37%73.920.4%$167.21m
IDXXIDEXX Laboratories, Inc. -3.97%425.573.8%$139.70m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.